108 related articles for article (PubMed ID: 12416557)
21. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
22. An autopsy case of incipient Pick's disease: immunohistochemical profile of early-stage Pick body formation.
Miki Y; Mori F; Tanji K; Kurotaki H; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2014 Aug; 34(4):386-91. PubMed ID: 24444359
[TBL] [Abstract][Full Text] [Related]
23. Four-repeat tau-positive Pick body-like inclusions are distinct from classic Pick bodies.
Motoi Y; Iwamoto H; Itaya M; Kobayashi T; Hasegawa M; Yasuda M; Mizuno Y; Mori H
Acta Neuropathol; 2005 Oct; 110(4):431-3. PubMed ID: 16158330
[No Abstract] [Full Text] [Related]
24. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology.
Bronner IF; ter Meulen BC; Azmani A; Severijnen LA; Willemsen R; Kamphorst W; Ravid R; Heutink P; van Swieten JC
Brain; 2005 Nov; 128(Pt 11):2645-53. PubMed ID: 16014652
[TBL] [Abstract][Full Text] [Related]
25. Preservation of nigral neurons in Pick's disease with Pick bodies: a clinicopathological and morphometric study of five autopsy cases.
Yokota O; Ishizu H; Terada S; Tsuchiya K; Haraguchi T; Nose S; Kawai K; Ikeda K; Kuroda S
J Neurol Sci; 2002 Feb; 194(1):41-8. PubMed ID: 11809165
[TBL] [Abstract][Full Text] [Related]
26. Gallyas-positive, tau-negative glial inclusions in Parkinson's disease midbrain.
Wakabayashi K; Takahashi H
Neurosci Lett; 1996 Oct; 217(2-3):133-6. PubMed ID: 8916090
[TBL] [Abstract][Full Text] [Related]
27. Quantification of the pathological changes in the temporal lobe of patients with a novel neurofilamentopathy: neurofilament inclusion disease (NID).
Cairns NJ; Armstrong RA
Clin Neuropathol; 2004; 23(3):107-12. PubMed ID: 15200288
[TBL] [Abstract][Full Text] [Related]
28. Immunolocalization of an amino-terminal fragment of apolipoprotein E in the Pick's disease brain.
Rohn TT; Day RJ; Catlin LW; Brown RJ; Rajic AJ; Poon WW
PLoS One; 2013; 8(12):e80180. PubMed ID: 24312462
[TBL] [Abstract][Full Text] [Related]
29. Senile plaque-like structures: observation of a probably unknown type of senile plaque by periodic-acid methenamine silver (PAM) electron microscopy.
Ikeda K; Haga C; Kosaka K; Oyanagi S
Acta Neuropathol; 1989; 78(2):137-42. PubMed ID: 2473593
[TBL] [Abstract][Full Text] [Related]
30. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
[TBL] [Abstract][Full Text] [Related]
31. C1q, the classical complement pathway protein binds Hirano bodies in Pick's disease.
Singhrao SK
Microsc Res Tech; 2013 Jun; 76(6):606-11. PubMed ID: 23512330
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitin and ubiquitin-related proteins in neurons and dendrites of brains of atypical Pick's disease without Pick bodies.
Furukawa Y; Iseki E; Hino H; Kanai A; Odawara T; Kosaka K
Neuropathology; 2004 Mar; 24(1):38-45. PubMed ID: 15068171
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitin-immunohistochemical investigation of atypical Pick's disease without Pick bodies.
Iseki E; Li F; Odawara T; Hino H; Suzuki K; Kosaka K; Akiyama H; Ikeda K; Kato M
J Neurol Sci; 1998 Aug; 159(2):194-201. PubMed ID: 9741407
[TBL] [Abstract][Full Text] [Related]
34. Morphometrical reappraisal of motor neuron system of Pick's disease and amyotrophic lateral sclerosis with dementia.
Ikeda K; Akiyama H; Arai T; Ueno H; Tsuchiya K; Kosaka K
Acta Neuropathol; 2002 Jul; 104(1):21-8. PubMed ID: 12070660
[TBL] [Abstract][Full Text] [Related]
35. Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease.
Muntané G; Dalfó E; Martínez A; Rey MJ; Avila J; Pérez M; Portero M; Pamplona R; Ayala V; Ferrer I
J Neurochem; 2006 Oct; 99(1):177-85. PubMed ID: 16987245
[TBL] [Abstract][Full Text] [Related]
36. Clustering of Pick bodies in patients with Pick's disease.
Armstrong RA; Cairns NJ; Lantos PL
Neurosci Lett; 1998 Feb; 242(2):81-4. PubMed ID: 9533399
[TBL] [Abstract][Full Text] [Related]
37. Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter.
Zhukareva V; Mann D; Pickering-Brown S; Uryu K; Shuck T; Shah K; Grossman M; Miller BL; Hulette CM; Feinstein SC; Trojanowski JQ; Lee VM
Ann Neurol; 2002 Jun; 51(6):730-9. PubMed ID: 12112079
[TBL] [Abstract][Full Text] [Related]
38. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.
Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL
Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372
[TBL] [Abstract][Full Text] [Related]
39. Silver staining profiles distinguish Pick bodies from neurofibrillary tangles of Alzheimer type: comparison between Gallyas and Campbell-Switzer methods.
Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
Acta Neuropathol; 2005 May; 109(5):483-9. PubMed ID: 15759128
[TBL] [Abstract][Full Text] [Related]
40. Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics.
Iwatsubo T; Hasegawa M; Ihara Y
Acta Neuropathol; 1994; 88(2):129-36. PubMed ID: 7985493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
